For research use only. Not for therapeutic Use.
X77(Cat No.:I015222) is a high-affinity non-covalent inhibitor that targets the main protease (Mpro) of SARS-CoV-2. It binds to the SARS-CoV-2 Mpro protein with a Kd value of 0.057 μM. The SARS-CoV-2 Mpro protein is the primary protease of the SARS-CoV-2 virus and is considered a crucial target for drug development against COVID-19.
Catalog Number | I015222 |
CAS Number | 2455518-33-7 |
Molecular Formula | C₂₇H₃₃N₅O₂ |
Purity | ≥95% |
Storage | Store at -20°C |
IUPAC Name | N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-pyridin-3-ylethyl]-1H-imidazole-5-carboxamide |
InChI | InChI=1S/C27H33N5O2/c1-27(2,3)20-11-13-22(14-12-20)32(26(34)23-17-29-18-30-23)24(19-8-7-15-28-16-19)25(33)31-21-9-5-4-6-10-21/h7-8,11-18,21,24H,4-6,9-10H2,1-3H3,(H,29,30)(H,31,33)/t24-/m1/s1 |
InChIKey | MUNFBYOTGGMQOS-XMMPIXPASA-N |
SMILES | CC(C)(C)C1=CC=C(C=C1)N(C(C2=CN=CC=C2)C(=O)NC3CCCCC3)C(=O)C4=CN=CN4 |
Reference | [1]. Sohini Chakraborti, et al. Drug Repurposing Approach Targeted Against Main Protease of SARS-CoV-2 Exploiting ‘Neighbourhood Behaviour’ in 3D Protein Structural Space and 2D Chemical Space of Small Molecules.<br>[2]. Alexander M Andrianov, et al. Computational discovery of small drug-like compounds as potential inhibitors of SARS-CoV-2 main protease. J Biomol Struct Dyn |